Related Experiment Videos
[Specific cerebral alpha 1-globulin in glial tumors]
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko
|July 1, 1985
Summary
Specific alpha 1-globulin (S alpha 1-GB) levels were elevated in neurological patients, particularly those with glial brain tumors. Malignant tumors showed increased S alpha 1-GB with decreased autoantibodies.
Area of Science:
- Biochemistry
- Immunology
- Neuro-oncology
Context:
- Investigates biomarkers for neurological disorders.
- Focuses on specific alpha 1-globulin (S alpha 1-GB) and its autoantibodies.
- Utilizes immunoenzyme assays for serum analysis.
Purpose:
- To assess the diagnostic potential of S alpha 1-GB and its autoantibodies in neurological conditions.
- To correlate S alpha 1-GB levels with glial brain tumor presence and malignancy.
- To explore the immunological mechanisms underlying altered S alpha 1-GB levels.
Summary:
- Serum S alpha 1-GB levels and autoantibodies were measured in donors and neurological patients.
- Elevated S alpha 1-GB was most common in patients with glial brain tumors.
- Malignant tumors were associated with increased S alpha 1-GB and decreased autoantibodies to it.
Impact:
- Suggests potential utility of S alpha 1-GB and autoantibody testing in diagnosing glial brain tumors.
- Provides insights into the immunochemical changes occurring in the presence of brain tumors.
- Highlights the role of S alpha 1-GB as a potential biomarker in neuro-oncology.